**Background**
Type I diabetes is a chronic condition characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to severe hyperglycemia. In the absence of sufficient insulin, the body shifts its metabolism toward the breakdown of fats, resulting in the production of ketone bodies. Among these, 3-Hydroxybutyric acid (β-Hydroxybutyric acid) is a primary metabolite that becomes significantly elevated during diabetic ketoacidosis. Beyond its role as an energy source, this metabolite is known to influence cellular membranes and physiological states, including the impairment of consciousness at high clinical concentrations. Understanding the interaction between ketone bodies and cellular structures is crucial for managing metabolic disorders. In this context, we will introduce a human endogenous metabolite – 3-Hydroxybutyric acid.
**Definition**
3-Hydroxybutyric acid is a ketone-based endogenous metabolite with a molecular weight of 104.10 and the chemical formula C4H8O3. According to the 3-Hydroxybutyric acid description, it serves as a key marker for metabolic shifts in type I diabetes.
**In Vitro Studies**
The 3-Hydroxybutyric acid biological activity has been extensively studied regarding its interaction with membrane lipids. In vitro experiments utilizing a DPPC monolayer model demonstrated that 3-Hydroxybutyric acid is capable of interacting with lipids and altering their phase behavior when present at clinical concentrations. Furthermore, research indicates that 3-Hydroxybutyric acid diminishes the interfacial viscosity of DPPC monolayers, suggesting a capacity to modulate the physical properties of cell membranes. These findings highlight the potential of the metabolite to disrupt membrane stability and function. For researchers seeking detailed experimental parameters, the 3-Hydroxybutyric acid technical information provides further guidance on its application in lipid research. In conclusion, 3-Hydroxybutyric acid is a metabolic byproduct that modulates membrane lipid properties and serves as a critical biomarker in diabetic research.
Keywords
3-Hydroxybutyric acid, 300-85-6, β-Hydroxybutyric acid, Endogenous Metabolite, metabolite, type, I, diabetes, membrane, lipids, Inhibitor, inhibitor, inhibit
References